Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$804,491
+$204,449 QoQ
Shares Held
6,563
+15.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#183
of 341 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 5%
Shared 22%
None 73%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $424,897,823 across 139 Biotechnology names. PTGX ranks #41 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
255,874 | $127,100,291 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
797,119 | $69,309,495 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
343,589 | $26,892,710 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,274 | $24,488,909 | |
| 5 | INCY |
Incyte Corp
|
205,071 | $23,246,847 | |
| 6 | EXEL |
Exelixis, Inc.
|
377,130 | $20,519,642 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
53,534 | $12,900,087 | |
| 8 | RPRX |
Royalty Pharma plc
|
180,772 | $10,135,884 |
All Filings in PTGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $804,491 | 6,563 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $600,042 | 5,693 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $790,338 | 9,049 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $572,493 | 8,618 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $537,334 | 9,722 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $447,088 | 9,245 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $503,961 | 13,056 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $640,845 | 14,241 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $389,327 | 11,236 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $345,019 | 11,926 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $258,306 | 11,265 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $187,900 | 11,265 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $331,163 | 11,990 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $275,770 | 11,990 | Shares | Sole | 2023-05-11 | |
| 2022-06-30 | $92,072 | 11,640 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||